This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignee: Fudan University. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Innovations of Inventor Yuan Tao
Introduction
Yuan Tao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of organic synthesis, particularly in the development of methods for synthesizing important chemical compounds. With a total of five patents to his name, Yuan Tao continues to push the boundaries of innovation in his field.
Latest Patents
Yuan Tao's latest patents include an enzyme-catalyzed method for synthesizing (2S, 3R)-2-substituted aminomethyl-3-hydroxybutyrate. This method involves preparing engineered bacteria containing a carbonyl reductase SsCR-encoding gene, creating a resting cell suspension of the engineered bacteria, and mixing the culture with substrate 2-substituted aminomethyl-3-one butyrate, glucose dehydrogenase, a cosolvent, glucose, and a cofactor. The process culminates in asymmetric carbonyl reduction to obtain the desired compound. Additionally, he has developed a method for preparing a key intermediate for the synthesis of statins. This method involves nucleophilic substitution of a halomethyl compound and a thiol reagent in an organic solvent to synthesize a thioether, which then undergoes a ketal exchange reaction with a carbonyl compound to yield the target product.
Career Highlights
Yuan Tao is affiliated with Fudan University, where he conducts research and develops innovative solutions in organic synthesis. His work has garnered attention for its practical applications in pharmaceuticals and biochemistry.
Collaborations
Yuan Tao collaborates with notable colleagues, including Fener Chen and Zedu Huang, who contribute to his research endeavors and enhance the impact of his innovations.
Conclusion
Yuan Tao's contributions to the field of organic synthesis exemplify the spirit of innovation and the importance of collaboration in advancing scientific knowledge. His patents reflect a commitment to developing methods that have significant implications for the pharmaceutical industry.